REGENCELL BIOSCIENCE HOLDINGS LIMITED
Last · NASDAQ$8.11-0.08 (-0.98%)close · yahoo · 19h ago
Market cap$4.02B495.9M sh
P/E · TTM-406fwd — · eps -0.02 · loss
Beta1.17vs S&P 500
Div yield0.00%annual · TTM
52w range
$4.51$69.00
Volume657.0Ksession
Loading chart…
OpenFilings analyst
Our analyst
From latest 20-F · 2026-10-07
- Operating Loss
- Research And Development
- Doj Investigation
- Share Based Compensation
- Registered Direct Offering
- Shareholder Litigation
Red flags
- Operating expenses rose from $3.77 million to $11.72 million; G&A professional fees increased to $3.71 million from $0.58 million, while G&A share-based compensation rose to $3.22 million from $0.20 million.
- The DOJ has requested documents and communications concerning share trading and corporate operational, financial, and accounting matters; no loss provision has been recorded.
- The May 2026 offering issued 985,222 shares for $18.62 million net proceeds; shares outstanding increased to 495.88 million from 494.49 million year over year.
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Documents
FormReporting forFiledFlags